Monoaryl phosphonate esters, designated as analogs of the transition state in the hydrolysis of carboxylic esters, were synthesized and used as haptens to generate specific monoclonal antibodies. Some of these antibodies react with cognate aryl carboxylic esters to release a fluorescent alcohol. The reaction appears to be stoichiometric; however, the activity is slowly regenerated under alkaline conditions or by treatment with hydroxylamine. Specificity is rigorous for esters ofp-trifluoroacetamidophenylacetic acid, demonstrating a structural correspondence with the phosphonate hapten.
competitive inhibitor of the reaction (K;, 35 nM); whereas the carboxylate product of ester hydrolysis is a less effective inhibitor (Ki, ca. 7500 nM). Chemical modification of side chain groups in the protein show a partial reduction in activity on acylation of lysine or nitration of tyrosine and a dramatic quenching upon modification of histidine. The evidence is discussed in terms of a mechanism in which amino acids of the antibody combining site participate in nucleophilic and/or general base catalysis. The properties of this system suggest that it is an example of enzymic transacylation where a deacylation step is not catalyzed. The possibility of deriving enzymic function from immunological specificity through this approach is advanced.
The immune system is the most prolific source of receptor molecules known; yet, it remains largely unexploited for the study of the relationship of ligand binding to enzymic function. Antibodies offer the ability to specify binding interactions toward any molecule of theoretical interest, and the consequences of that interaction may then be investigated. The central tenet of biological catalysis ascribes enzymic rate accelerations to the changes in binding interactions along a reaction coordinate such that energy of binding, and thus stabilization ofthe complex, increases as bound substrates or products approach the bound transition state (1, 2) . Evidence for this theory comes from the observation that substances that are thought to model the presumed transition states are often strongly bound to the enzymes as competitive inhibitors (3, 4) . Given the availability oftransition state analogs and the diversity of immunological receptors, one can ask whether it is possible to derive a chemical function from a pure binding function by selecting an antibody-antigen pair to define the optimal binding in a transition-state receptor complex.
Immunological binding has been recognized as a potential basis for experimentally diverting binding interactions to catalytic processes (5) . Sporadic attempts to introduce reactive groups into an antibody's combining site have been unsuccessful (6) . Some monoclonal antibodies are reported to be fortuitously endowed with nucleophilic residues that allow a reaction with an activated ester appendage on a homologous hapten recognized by the antibody (7) (8) (9) . In these cases, the rate of acylation of the nucleophile is presumably accelerated by its proximity to a binding site of the haptenic fragment.
We have employed synthetic substances that simulate the appearance of high energy intermediates in ester hydrolysis to induce antibodies with the ability to react chemically upon binding related substrates. The Protein Modification and Inactivation. Antibody preparations were inactivated without introducing fluorescent products by addition of the activated ester 8 in dioxane to a solution of the IgG (5 mg/ml) in Tris-HCl (50 mM, pH 6.5) at a ratio of 5 mol of 8 per mol of IgG. The loss of activity was confirmed by reaction with 5. Protein modification was performed analogously, by addition of a dioxane solution of the reagent, at known concentration, to the antibody. The solution was incubated for 30 min, then filtered through Sephadex G-25. The activity remaining was compared to control samples. Aliquots of IgG (5 mg/ml), inactivated with 8, were diluted with 4 vol of phosphate buffer (50 mM, pH 4-9, at intervals of 1 pH unit); any pH change was recorded; and the sample was stored at 4°C for 24 hr. Activity was checked by dilution of each sample 
RESULTS
The synthetic procedures for the preparation of the phosphonate derivatives are outlined in Fig. 1 . We found that the introduction of a trifluoroacetyl group in the aminobenzylphosphonate simplified further synthetic operations in which the phosphonyl chloride is required. The dipicolinic acid appendage of 3 and 4 offers an additional binding interaction between an antibody and the phenolic portion of these structures. A detailed account of thejustification of this choice of structure and related studies will be reported elsewhere. Nitrophenyl esters of p-trifluoroacetamidobenzylphosphonates were useful as intermediates in the scheme for coupling of the haptens to carrier proteins by reduction of the nitro group to an amine function and acylation of this with a heterobifunctional adipic acid derivative (unpublished results). The N-hydroxysuccinimidyl-activated ester appendage in the phenolic ring (1 and 3) allows efficient coupling to carrier proteins (keyhole limpet hemocyanin or bovine serum albumin) in aqueous buffer solutions.
A specific high titer serum resulted from immunizations with the keyhole limpet hemocyanin conjugates. Each fusion procedure yielded 50-100 hybridomas secreting organophosphonate-specific antibody. Of these, the IgG producers with titer above 1:64 (10-18 hybridomas) were subcloned and propagated as ascites tumors. The IgG fraction was isolated from ascites fluid in greater than 90% purity. Three of the purified monoclonal IgG, obtained from immunization with 3, showed measurable hydrolysis of 5. Activity was found to be specific for the hydrolysis of the ester possessing the trifluoroacetamide substituent in the carboxylic acid, as required for correspondence with the phosphonate structure. 6 did not react with these antibodies.
The most effective of the three antibodies, an IgG from hybridoma 6D4, was examined in more detail. A (21) , quenches all activity at a reagent/protein ratio of less than 10 
DISCUSSION
The most direct demonstration of the validity of the Pauling theory of catalysis would be the de novo expression of catalytic phenomena in an arbitrary receptor that is evolved with the imperative that it must bind a reacting ligand in its transition state structure most effectively. Immunological specificity offers a scenario for this experiment. We have sought to obtain monoclonal antibodies to substances that mimic the structure of a transition state or tetrahedral intermediate in ester hydrolysis. Three of 12 monoclonal IgGs obtained to 3 also expressed an esterolytic function, indicating a high probability for success through this design. The chemical properties of these monoclonal antibodies indicate that they act as stoichiometric reactants with activated esters of 7. The enzyme-like specificity of these proteins is demonstrated by the failure to observe a reaction with analogous esters in which an acetamide replaces the trifluoroacetamide substituent in the aromatic ring of the substrate. The cleavage of these esters is not markedly accelerated by other immunoglobulins, including many antihapten antibodies that recognize the p-trifluoroacetanilide structure in an immunoassay. The fluorescence change that allows detection of the reaction with coumarin esters is not the result of noncovalent protein-ligand interactions but correlates with release of 7-hydroxycoumarin. Noncovalent interactions typically result in a shift in the fluorescence maximum of a bound ligand and are reversible upon displacement of the ligand. Neither of these effects is observed in this case. Antigenic compounds do not reverse fluorescence changes upon addition to a reaction mixture. Also, maximum fluorescence intensities are proportional to the concentration of coumarin when the ester is hydrolyzed either with excess antibody or with pig liver esterase.
Recovery of activity upon exposure of the reaction product to alkaline buffer or hydroxylamine is reminiscent of the behavior of enzymes like chyMotrypsin, which form covalent intermediates on hydrolysis of acyl compounds (22) . An acyl intermediate implies a nucleophilic transacylation process.
The increase in the rate constant (kobs/Km,) with the increase in pH may reflect the ionization of an active site nucleophile in the antibody. Chemical modification of the protein shows the activity is reduced by lysine-, tyrosine-, and especially histidine-specific reagents. The dramatic effect of histidine modification would suggest that the imidazole group is participating in the transacylation reaction. This might involve the direct formation of a stable acylated histidine as the product or perhaps its transient involvement in a two-step mechanism with acyl transfer to tyrosine for example. Alternatively, the imidazole may act as a general base catalyst in the acylation of tyrosine directly (Fig. 3) . The observed return of activity under alkaline condition, but not in acid (pH 4), supports the notion of an acylated tyrosine as product but does not exclude an acid-stable acyl histidine. Since immunoassays reveal that imidazole modification also alters binding ability, it is difficult to draw conclusions regarding the contribution of imidazole to binding of substrate versus catalysis (K, vs. kcat).* Acylation of lysine by 5 seems implausible since the formation of an amide should irreversibly inactivate the protein. The effect of lysine modification at high reagent concentration may be attributed to changes in the protein structure that alter the binding properties. It might be argued that the activity we observe is due to arbitrary structures of the combining site that are independent of transition state stabilization. Previous reports of antibody enhanced ester hydrolysis have proposed that nucleophilic groups at or near the combining site of ordinary anti-hapten IgG are responsible for the observed esterolysis rates (7) (8) (9) . However, the kinetic parameters show such reactions are at least two orders of magnitude slower (kob5, 0.0052-0.014 min-) than those we report, even though homologous haptenic esters seem to bind as well or better than the natural haptens. The hydrolysis products, in particular, are bound tightly and efficiently inhibit the reaction, as would be expected if ligand binding serves merely to reduce the entropic barrier of a bimolecular reaction (23) . We find that hydrolytic activity of the antibody to 3 is inhibited less significantly by 7 than by 4 or 2.t The value of Km with 5
(1-1.2 AM) provides an upper estimate of the dissociation constant K, with this substrate that is greater than Ki for phosphonate inhibitors. The relation ofthese constants to the rate constant kob, show this process is substantially different than those reported previously. It seems unlikely that the rates observed here are-4iiere1y due to the tight binding of substrate or product in the proximity of casual nucleophiles. Though the contribution of transition state binding to the acceleration of acyl transfer is difficult to assess from this information, it is clear that immunological binding can express enzymic properties. Spectacular rates have been claimed for acylation of hydroxyl groups of cyclodextrins and other synthetic complexing agents by the very reactive p-nitrophenyl esters (24) (25) (26) . Though the interpretation of these rate factors is controversial, the comparisons are informative in the context of the structural studies. Substrate structures that lead to accelerated transacylation are presumed to have binding geometries that favor formation of the tetrahedral intermediates or transition state. The acyl transfer reaction in the antibody combining site may be likened to these models, and the rate constants may be related to some reference reaction.
The pseudo-first order rate constant, 1.3 x 10-2 sec1, for the antibody process weighed against the background rate of hydrolysis of its substrate 5 or the nonsubstrate 6 under the same conditions (kbuffer 9 x 10-6 sec') reveals a 1.5 x 103 rate acceleration. The relation of these rate constants should *Thus, stabilization of a charge bearing oxygen at the acyl center is not sufficient to account for-the magnitude of the hapten binding. Such an interaction might provide a mechanism for acid-catalyzed hydrolysis of the bound ester without necessarily evoking transition state stabilization. It would be surprising to find that the phosphonate structure is descriptive of a mechanism that requires formation of a covalent intermediate since it defines the tetrahedral center as a form of hydrate that would exclude other nucleophiles. The participation of a nucleophilic residue of the binding site might provide the lowest energy pathway in the hydrolysis of esters with good leaving groups. The catalysis of ester hydrolysis by imidazole is subject to changes in mechanism upon change in the leaving group basicity (27) . In this example, a shift in mechanism from covalent to noncovalent catalysis might be possible. Similarities in the binding interactions that stabilize the transition state in a covalent mechanism and a noncovalent mechanism may exist in such a system (28, 29 We are grateful to Diane Schloeder, Jeanne Portelance, and Susan Crawford for technical assistance, and to Dr. Donald Hilvert for helpful discussions and the use of computer programs. This work was supported in part by Grant GM35318 from the National Institutes of Health.
